Health Care [ 8/12 ] | Health Care Equipment & Supplies [ 43/76 ]
NASDAQ | Common Stock
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components.
The company operates through two segments, Medical and Industrial.
The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses.
The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications.
The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users.
It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia.
Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 1, 24 | 0.14 Decreased by -62.16% | 0.19 Decreased by -26.32% |
| May 2, 24 | 0.16 Decreased by -38.46% | 0.21 Decreased by -23.81% |
| Feb 6, 24 | 0.06 Decreased by -71.43% | 0.11 Decreased by -45.45% |
| Nov 14, 23 | 0.45 Increased by +7.14% | 0.35 Increased by +28.57% |
| Aug 1, 23 | 0.37 Increased by 0.00% | 0.32 Increased by +15.62% |
| May 2, 23 | 0.26 Decreased by -29.73% | 0.18 Increased by +44.44% |
| Jan 31, 23 | 0.21 Decreased by -16.00% | 0.20 Increased by +5.00% |
| Nov 15, 22 | 0.42 Decreased by -6.67% | 0.36 Increased by +16.67% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 206.20 M Decreased by -9.64% | 1.40 M Decreased by -65.85% | Increased by +0.68% Decreased by -62.21% |
| Dec 31, 23 | 190.00 M Decreased by -7.59% | -500.00 K Decreased by -116.13% | Decreased by -0.26% Decreased by -117.45% |
| Sep 30, 23 | 227.40 M Decreased by -1.73% | 31.90 M Increased by +143.51% | Increased by +14.03% Increased by +147.79% |
| Jun 30, 23 | 232.20 M Increased by +8.25% | 9.10 M Increased by +10.98% | Increased by +3.92% Increased by +2.52% |
| Mar 31, 23 | 228.20 M Increased by +6.29% | 4.10 M Decreased by -46.05% | Increased by +1.80% Decreased by -49.24% |
| Dec 31, 22 | 205.60 M Increased by +3.42% | 3.10 M Increased by +121.43% | Increased by +1.51% Increased by +114.11% |
| Sep 30, 22 | 231.40 M Increased by +2.25% | 13.10 M Increased by +50.57% | Increased by +5.66% Increased by +47.26% |
| Jun 30, 22 | 214.50 M Increased by +1.56% | 8.20 M Decreased by -31.67% | Increased by +3.82% Decreased by -32.72% |